Surprisingly, a large number of GLP-1 users are reporting reduced use or total abstinence from substances like alcohol, cannabis, and nicotine
Importantly, the current clinical landscape reflects ongoing interest in this concept: while Roche has discontinued development of an NPY2R agonist, Gubra is advancing an NPY2R program in collaboration with Boehringer Ingelheim, suggesting that the hypothesis of pharmacologically optimized Y2 receptor engagement retains translational credibility
Its possible to keep your skin in control without having to stop your GLP-1 treatment
USA 76 , 13031307 (1979)
However, its symptoms, similar to other gastrointestinal issues, are experienced by about 1 in 4 adults in the U.S
As collagen depletion is one of the biggest factors leading to visible signs of aging, this effect has made GHK-Cu a coveted ingredient when it comes to anti-aging solutions